论文部分内容阅读
本组56例,男38例,女18例,年龄18~77岁,平均42岁,频发室早33例,房早10例,房颤4例,阵发性室上速4例,交界性早搏2例,窦性心动过速1例,房扑1例,阵发性室速1例。病因:心肌炎后遗症24例,冠心病15例,心肌病2例,高心病3例,风心病3例,甲亢性心脏病1例,特发性(不明原因)8例。最长病史10年,最短半个月,多数已用过其它抗心律失常药。心律平口服量100~200mg,每日3次,室上速和窒速者用心律平70~140mg 加5%葡萄糖20ml 静注,终止后即用150mg 口服维持,每日3次。2~3周为疗程,以后根据情况逐渐减量或停药。服药前后查肝
The group of 56 patients, 38 males and 18 females, aged 18 to 77 years, mean 42 years, 33 cases of frequent as early as possible, as early as 10 cases of room, atrial fibrillation in 4 cases, paroxysmal supraventricular tachycardia in 4 cases, border 2 cases of premature beats, 1 case of sinus tachycardia, 1 case of atrial flutter and 1 case of paroxysmal ventricular tachycardia. Etiology: 24 cases of myocarditis sequelae, 15 cases of coronary heart disease, cardiomyopathy in 2 cases, 3 cases of high heart disease, rheumatic heart disease in 3 cases, hyperthyroid heart disease in 1 case, idiopathic (unexplained) in 8 cases. The longest history of 10 years, the shortest half a month, most have used other anti-arrhythmic drugs. The oral dose of heart rhythm 100 ~ 200mg, 3 times a day, supraventricular tachycardia and choking speed with rhythm 70 ~ 140mg plus 5% glucose 20ml intravenous injection, 150mg orally maintained after termination, 3 times daily. 2 to 3 weeks for the course of treatment, after the gradual reduction or withdrawal according to the circumstances. Check the liver before and after taking the medicine